What Is the Best Painkiller for Neck Pain?

Determine the most effective painkiller for your neck pain. We compare OTC and prescription options based on severity, cause, and safety profiles.

For most ordinary neck pain, an over-the-counter anti-inflammatory such as ibuprofen or naproxen is the closest thing to a default “best” painkiller supported by clinical evidence. European and North American treatment guidelines consistently give oral anti-inflammatory drugs a weak-to-moderate recommendation as first-line pharmacotherapy for neck pain without nerve involvement. But “best” is doing a lot of work in that sentence: the right painkiller shifts considerably depending on whether your pain is acute or chronic, whether muscle spasm is involved, and whether a compressed nerve is sending pain down your arm. The honest answer is that there is no universal winner, and several medications that people reach for first, especially opioids, perform worse than most assume.

Anti-Inflammatories as the Starting Point

Non-steroidal anti-inflammatory drugs, usually referred to as NSAIDs, include familiar names like ibuprofen (Advil, Motrin) and naproxen (Aleve). A systematic review of systematic reviews conducted under the Ontario Protocol for Traffic Injury Management found that oral NSAIDs may be more effective than placebo for neck-associated disorders. That phrasing, “may be more effective,” is worth noting. The evidence is real but not overwhelming. NSAIDs beat placebo, yet the margin is modest enough that guidelines stop short of a strong endorsement.

Why are they still the go-to? Partly because neck pain from everyday strain, poor posture, or minor injury usually involves local inflammation, and NSAIDs directly target that. They also reduce pain signaling more broadly, which helps with stiffness and the muscle guarding that often makes neck pain worse. For uncomplicated acute neck pain lasting a few days to a few weeks, most guidelines recommend NSAIDs alongside reassurance, staying active, and gentle range-of-motion exercises.

Acetaminophen (paracetamol, Tylenol) is the other common over-the-counter option. It reduces pain but does not address inflammation. For neck pain specifically, the evidence favoring acetaminophen over placebo is thinner than for NSAIDs, which is why most clinical practice guidelines lean toward anti-inflammatories when a patient can safely take them.

Topical Painkillers Deserve More Attention

One of the more underappreciated options for neck pain is a topical NSAID, particularly diclofenac gel. A randomized, double-blind trial testing diclofenac diethylamine gel on acute neck pain found that pain scores dropped by about 75% from baseline after 48 hours, compared with roughly 23% in the placebo group. Nearly all patients receiving the gel responded to treatment, compared to fewer than one in ten on placebo. Those numbers are striking, and the advantage of a topical formulation is that it delivers the drug locally with far less systemic exposure, meaning fewer stomach and cardiovascular concerns than popping pills.

Capsaicin-based creams are another topical route. A multicenter trial tested a combination gel of diclofenac plus capsaicin against each ingredient alone. The combination produced meaningful pain relief, though capsaicin alone performed similarly well. Neither clearly outperformed the other. Capsaicin works by desensitizing pain-sensing nerve fibers over time, so it may complement or sometimes substitute for a topical NSAID if you find the warming sensation tolerable.

If your neck pain is mild to moderate and you want to minimize side effects, a topical diclofenac gel is a reasonable first move, and the trial data for acute neck pain is surprisingly strong.

When Muscle Spasm Is Part of the Picture

Neck pain often arrives with muscle spasm, that tight, knotted feeling where the muscles around your cervical spine clamp down protectively. When that happens, the pain can feel less like inflammation and more like your neck is locked in place. This is where muscle relaxants enter the conversation.

Cyclobenzaprine (brand name Flexeril) is the most studied muscle relaxant for neck and back spasm. A trial comparing low-dose cyclobenzaprine to ibuprofen, and to the two drugs combined, found that all three approaches produced significant improvements in pain, spasm, and overall patient-rated improvement after three and seven days. There was no clear winner among the three groups. In other words, a muscle relaxant alone worked about as well as an NSAID alone, and stacking both did not add a measurable advantage in that study. All three options were well tolerated, though the most common side effects of cyclobenzaprine were drowsiness, fatigue, and dizziness.

An extended-release form of cyclobenzaprine was tested in two identically designed placebo-controlled trials. One trial found the 15 mg dose effective; the other found the 30 mg dose effective, both after about four days. However, the studies were not large enough to confirm differences between doses, and not all outcome measures reached statistical significance. The practical takeaway: if spasm is a dominant feature of your neck pain, a short course of a muscle relaxant can help, but the benefit over an NSAID alone is not dramatic. Clinical guidelines mention muscle relaxants as an option for acute neck pain lasting less than three months.

Neck Pain with Nerve Involvement Changes Everything

The medications above work reasonably well for “mechanical” neck pain, the kind caused by strain, posture, or mild injury with no nerve compression. But if pain radiates down your arm, comes with numbness or tingling, or results from a disc herniation pressing on a nerve root (cervical radiculopathy), the painkiller landscape shifts.

Pregabalin (Lyrica) is a nerve-pain medication originally developed for epilepsy and later found to calm overactive pain signaling. An eight-week observational study in Japanese primary care settings found that pregabalin significantly improved pain scores and disability compared to usual care in patients with chronic cervical radiculopathy that sent pain into the arm. A separate pilot trial in cervical myelopathy patients found that adding pregabalin to treatment was more effective than opioids alone for neuropathic pain during the first four weeks, though the advantage faded after that. Common side effects include dizziness and drowsiness, similar to muscle relaxants.

A short course of oral corticosteroids is another option for radicular neck pain. In a placebo-controlled trial of oral prednisolone for cervical radiculopathy, about 76% of patients in the steroid group achieved clinically meaningful improvement, compared to 30% on placebo. A systematic review confirmed that oral steroids can be considered a reasonable conservative option based on this evidence, though it also noted that the total body of research remains thin. Steroids are not painkillers in the traditional sense; they work by reducing the inflammation squeezing the nerve root. They are typically prescribed as a short tapering course rather than ongoing treatment.

Opioids Do Not Work for Routine Neck Pain

This is probably the most important finding to highlight, because it conflicts with what many patients expect. The OPAL trial, a large randomized placebo-controlled study published in The Lancet, found no significant difference in pain severity between opioids and placebo for acute non-specific low back or neck pain at six weeks. The opioid group averaged a pain score of 2.78 versus 2.25 in the placebo group, a gap that did not reach statistical significance. Meanwhile, the opioid group experienced more side effects, including higher rates of constipation. The authors were blunt in their conclusion: opioids should not be recommended for these conditions.

A broader systematic review with meta-analysis of opioids for acute musculoskeletal pain found that oral opioids provide only a small benefit over placebo for pain in the short term, with high-certainty evidence. The effect on disability was uncertain. Critically, opioid groups had meaningfully higher rates of adverse events. For the average person with a stiff, sore neck, reaching for codeine or tramadol is not just unhelpful, it adds risk without a meaningful payoff.

Safety Trade-Offs with NSAIDs

If NSAIDs are the first-line choice, they are not without downsides. The two major concerns are gastrointestinal damage and cardiovascular risk. NSAIDs can irritate the stomach lining and, with prolonged use, contribute to ulcers and GI bleeding. Selective COX-2 inhibitors (like celecoxib) were developed to reduce stomach problems, and they do lower GI risk, but at the cost of a potentially increased cardiovascular risk.

For short-term use over a few days to two weeks, these risks are small for most healthy adults. The concern grows with longer use and in people with existing stomach problems, kidney disease, or heart disease. Older adults face a compounded version of these risks. Guidelines for spine-related pain in older adults emphasize using the lowest effective dose, accounting for reduced kidney and liver function, and being cautious about drug interactions with other medications. For elderly patients, topical NSAIDs often make more sense than oral ones precisely because they deliver less drug systemically.

The Risk of Taking Painkillers Too Often

One pattern that catches people off guard is that daily or weekly use of painkillers can itself become a driver of chronic pain. A large population-based study (the Head-HUNT Study) found that people who used analgesics daily or weekly at baseline had roughly double the risk of developing chronic neck pain at follow-up. Among those who overused analgesics, the association was even stronger, with a relative risk of about seven times higher for chronic neck pain. A companion analysis confirmed a similar pattern, showing that the association between analgesic overuse and chronic neck pain was statistically robust even after adjusting for other factors.

This does not mean that taking ibuprofen for a few days after tweaking your neck will make things worse. The concern is with frequent, sustained use, especially when pain is becoming chronic and the instinct is to keep medicating rather than pursuing other strategies. People with medication-overuse headache often have coexisting neck pain, and when the overuse pattern is broken, neck pain severity tends to drop as well. A study of over 600 patients with medication-overuse headache found that those who recovered from the overuse pattern saw a sharp decrease in severe neck pain compared to those who did not.

The Placebo Effect in Neck Pain Is Unusually Large

Researchers studying neck pain have noticed something that complicates every painkiller trial: the placebo response is huge. A pooled analysis of placebo-treated patients in neck pain studies found that people with higher initial pain scores and shorter symptom duration were most likely to improve on placebo alone. In the subgroup with disease duration under four months, about 76% of placebo-treated patients experienced a meaningful response. Among those with higher initial pain, the figure reached 90%.

This does not mean neck pain is imaginary. What it means is that acute neck pain tends to improve on its own, and the ritual of receiving treatment, whether that treatment contains an active ingredient or not, accelerates the improvement. It also means that the modest margins we see in NSAID trials may partly reflect the fact that the placebo arm is already doing quite well, making it harder for any drug to stand out. If you have had acute neck pain that seemed to get better quickly after taking a painkiller, some of that improvement was probably going to happen anyway.

Injections for Pain That Will Not Quit

When oral or topical painkillers are not cutting it and the pain has been going on for months, some people end up considering injections. Cervical facet joint injections involve placing a corticosteroid directly into the small joints at the back of the cervical spine. A study of patients with cervical facet joint pain syndromes found that injections produced immediate pain reduction across different diagnostic groups, though the duration of relief varied. Patients with associated disc herniations had longer-lasting symptom relief than those with myofascial pain syndrome or whiplash.

More recently, research has explored whether imaging can predict who will respond best to these injections. A study using SPECT imaging (a type of nuclear medicine scan) to identify which specific joints are inflamed found that patients with positive SPECT findings had a treatment success rate of about 63% at one month, compared to roughly 38% in those without positive imaging findings. The implication is practical: if a clinician can identify the exact joint causing the problem, the injection is more likely to help. Facet joint injections are not a first resort. They are typically considered after simpler medications and physical approaches have been tried.

CBD and Cannabinoids

Cannabidiol (CBD) products have become enormously popular for pain, and surveys suggest that a significant proportion of people with spine complaints try them. In one anonymous survey of patients with spine-related pain, about 37% of CBD users said they initially tried it specifically for neck pain. The most popular formulation was oil, and close to half reported pain relief, though roughly a quarter said they experienced no benefit at all. Most users learned about CBD from friends or family rather than from a doctor.

High-quality clinical trial data for CBD in neck pain is essentially nonexistent at this point. The most detailed published evidence is a single case report describing a patient with cervical spondyloarthritis-related pain who, after a slow titration of full-spectrum medicinal cannabis oil over about 90 days, reported complete pain resolution, return to physical activity, and discontinuation of other analgesics. That is one patient. It is interesting but not evidence on which to base treatment decisions. The gap between the popularity of CBD and the scientific evidence supporting it for neck pain remains wide, and the unregulated market means product quality varies enormously.

Medications Work Better When Combined with Movement

Almost every guideline on neck pain emphasizes that medication alone is not the whole answer. The consistent recommendation across European guidelines is a combination of reassurance, education, exercise, and manual therapy alongside any oral or topical medication. Painkillers lower the barrier to moving, and movement is what actually resolves most acute neck pain episodes. Resting the neck in a collar, by contrast, tends to slow recovery.

For chronic neck pain that has been present for more than three months, the pharmacotherapy options get less impressive across the board, and physical approaches become even more central. This is where structured exercise programs, manual therapy, and in some cases psychological therapies for pain management carry relatively more weight. The guideline from the OPTIMa Collaboration recommends structured patient education combined with range-of-motion exercises or multimodal care that includes mobilization for early-stage neck pain, and similar but more intensive approaches for persistent cases. Thinking of painkillers as something that buys you the comfort to start exercising, rather than as a standalone fix, is probably the most useful framing for most people.